SkinHealth Systems (SKIN) Cash from Financing Activities (2020 - 2026)
SkinHealth Systems' (SKIN) quarterly Cash from Financing Activities came in at -$224000.0 in Q2 2026, up 99.87% year-over-year from -$112072.4 in Q2 2025, and up 98.93% quarter-over-quarter from -$20.9 million in Q1 2026.
Powered by 
Analysis
SkinHealth Systems (SKIN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Cash from Financing Activities for 7 consecutive years, with -$224000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 99.87% year-over-year to -$224000.0 in Q2 2026; TTM through Jun 2026 was -$22.4 million, a 87.14% increase from a year earlier, with the FY2025 full-year figure at -$174.9 million, down 10.47% from the prior year.
- Cash from Financing Activities was -$224000.0 for Q2 2026 at SkinHealth Systems, up from -$20.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at -$204000.0 in Q3 2024 and troughed at -$173.4 million in Q2 2025.
- A 5-year average of -$33.2 million and a median of -$2.1 million in 2022 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 99.87% in 2026, down 8262.4% in 2026.
- Over 5 years, Cash from Financing Activities stood at -$102.5 million in 2022, then soared by 69.4% to -$31.4 million in 2023, then jumped by 97.54% to -$770000.0 in 2024, then soared by 33.51% to -$512000.0 in 2025, then surged by 56.25% to -$224000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$224000.0 (Q2 2026), -$20.9 million (Q1 2026), and -$512000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | SkinHealth Systems | 89.77 Mn | -116.30 Mn | 49.34 Mn | -224,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -224,000.00 |
| Mar 31, 2026 | -20.91 Mn |
| Dec 31, 2025 | -512,000.00 |
| Sep 30, 2025 | -803,000.00 |
| Jun 30, 2025 | -173.36 Mn |
| Mar 31, 2025 | -250,000.00 |
| Dec 31, 2024 | -770,000.00 |
| Sep 30, 2024 | -204,000.00 |
| Jun 30, 2024 | -98.75 Mn |
| Mar 31, 2024 | -58.62 Mn |
| Dec 31, 2023 | -31.36 Mn |
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -1.55 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | -102.48 Mn |
| Sep 30, 2022 | -100.00 Mn |
| Jun 30, 2022 | -1.98 Mn |
| Mar 31, 2022 | -783,000.00 |
| Dec 31, 2021 | 188.21 Mn |
| Sep 30, 2021 | 637.78 Mn |